Tech Company Financing Transactions
EnChannel Medical Funding Round
Lilly Asia Ventures and Lapam Capital participated in a $82.2 million Series B funding round for EnChannel Medical. The funding round was recorded on 5/1/2025.
Transaction Overview
Company Name
Announced On
5/1/2025
Transaction Type
Venture Equity
Amount
$82,200,000
Round
Series B
Investors
Lilly Asia Ventures (Lead Investor)
Proceeds Purpose
Proceeds from the Series B round will accelerate product development and advance clinical registration trials both in China and internationally.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
173 Technology Dr. 100
Irvine, CA 92619
USA
Irvine, CA 92619
USA
Phone
Website
Email Address
Not Recorded
Overview
Founded in 2020 by medical and industry experts in electrophysiology, EnChannel Medical is a pioneering cardiac technology company with headquarters in Guangzhou, China and a subsidiary in Irvine, CA. The company's global team is committed to developing intuitive, safer, and more effective personalized solutions to assist electrophysiologists in treating patients with complex cardiac arrhythmias.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jun Feng
Chief Scientific Officer
Graydon Beatty
Chief Technical Officer
Min Zhu
Browse more venture capital transactions:
Prev: 5/1/2025: Stately Bio venture capital transaction
Next: 5/1/2025: Dream Games venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs